PAWC
NVO

P.A.W. Capital’s Novo Nordisk NVO Stock Holding History

P.A.W. Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-40,000
Closed -$963K – 67
2017
Q3 		$963K Sell
40,000
-10,000
-20% -$226K 1.01% 42
2017
Q2 		$1.07M Buy
50,000
+10,000
+25% +$202K 1.08% 39
2017
Q1 		$686K Buy
+40,000
New +$696K 0.69% 60

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

P.A.W. Capital's NVO Position: Q4 2017 in Review

P.A.W. Capital sold out of Novo Nordisk (NVO) in Q4 2017, closing a stake of 40,000 shares — an estimated $963K sold.

P.A.W. Capital first reported a position in NVO in Q1 2017 and held it in 3 quarters. The position peaked at $1.07M in Q2 2017. 552 funds tracked by Wall St. Rank hold NVO as of Q4 2017.

  • P.A.W. Capital reported no remaining Novo Nordisk position as of Q4 2017 after selling out during the quarter.
  • P.A.W. Capital sold 40,000 Novo Nordisk shares in Q4 2017, an estimated $963K.
  • P.A.W. Capital first reported a position in Novo Nordisk in Q1 2017 and held it in 3 quarters.
  • P.A.W. Capital's Novo Nordisk position peaked at $1.07M in Q2 2017.
  • 552 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2017.

Based on P.A.W. Capital's 13F filing for Q4 2017, filed 31 Jan 2018.